Impact of the COVID-19 pandemic on inflammatory bowel disease patients: A review of the current evidence

Table 1 Latest International Organization for the Study of Inflammatory Bowel Disease/European Crohn’s and Colitis Organization recommendations for coronavirus disease 2019 infected inflammatory bowel disease-patients[101]

COVID-19 symptomatology	SARS-CoV-2 status	Recommendation
Asymptomatic	Non-tested	Do not withhold therapy (reduce corticosteroid use if possible)
Asymptomatic	Positive	Withhold therapy for 10 days1
Symptomatic	Positive	Withhold therapy until all of the following is fulfilled1: (1) At least 10 days has passed since symptoms onset; (2) Improvement in respiratory symptoms; and (3) Days without fever (without the use of antipyretics)

¹If clinical presentations imply that therapy should not be postponed, despite meeting the clinical criteria stated above, guidelines recommend moving ahead with the scheduled treatment. COVID-19: Coronavirus disease 2019; SARS-CoV-2: Severe acute respiratory syndrome coronavirus 2.